A Duke study shows the experimental drug SBI-810 blocks pain at its source—calming nerve signals without the side effects of opioids. In mice, it eased pain from surgery, bone fractures, and nerve injury without causing sedation or constipation.

More than 300 volunteers and friends joined Duke Health leaders, faculty, students, and staff for a special weekend May 1-3 highlighting the critical role of philanthropy in driving  innovation, discovery, and patient care. 

Study led by Duke School of Medicine reveals cancer’s weak spot – a protein that helps cells make energy and stops cancer from growing.

Professor of Medicine Michael Hershfield's research has transformed the lives of patients with rare immunodeficiencies and treatment-resistant gout. Now he's made a philanthropic gift to support early career physician-scientists at Duke.